1. Home
  2. CNMD vs LIVN Comparison

CNMD vs LIVN Comparison

Compare CNMD & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNMD
  • LIVN
  • Stock Information
  • Founded
  • CNMD 1970
  • LIVN 1987
  • Country
  • CNMD United States
  • LIVN United Kingdom
  • Employees
  • CNMD N/A
  • LIVN N/A
  • Industry
  • CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CNMD Health Care
  • LIVN Health Care
  • Exchange
  • CNMD Nasdaq
  • LIVN Nasdaq
  • Market Cap
  • CNMD 1.7B
  • LIVN 2.1B
  • IPO Year
  • CNMD 1987
  • LIVN 1993
  • Fundamental
  • Price
  • CNMD $56.94
  • LIVN $44.10
  • Analyst Decision
  • CNMD Buy
  • LIVN Strong Buy
  • Analyst Count
  • CNMD 5
  • LIVN 7
  • Target Price
  • CNMD $62.20
  • LIVN $59.29
  • AVG Volume (30 Days)
  • CNMD 311.9K
  • LIVN 938.0K
  • Earning Date
  • CNMD 07-30-2025
  • LIVN 07-30-2025
  • Dividend Yield
  • CNMD 1.41%
  • LIVN N/A
  • EPS Growth
  • CNMD 46.38
  • LIVN N/A
  • EPS
  • CNMD 3.81
  • LIVN N/A
  • Revenue
  • CNMD $1,315,998,000.00
  • LIVN $1,275,380,000.00
  • Revenue This Year
  • CNMD $6.27
  • LIVN $8.10
  • Revenue Next Year
  • CNMD $5.62
  • LIVN $5.76
  • P/E Ratio
  • CNMD $14.93
  • LIVN N/A
  • Revenue Growth
  • CNMD 4.32
  • LIVN 7.62
  • 52 Week Low
  • CNMD $46.00
  • LIVN $32.48
  • 52 Week High
  • CNMD $78.58
  • LIVN $61.40
  • Technical
  • Relative Strength Index (RSI)
  • CNMD 50.54
  • LIVN 59.34
  • Support Level
  • CNMD $54.77
  • LIVN $42.44
  • Resistance Level
  • CNMD $58.27
  • LIVN $43.61
  • Average True Range (ATR)
  • CNMD 1.63
  • LIVN 1.01
  • MACD
  • CNMD -0.31
  • LIVN -0.16
  • Stochastic Oscillator
  • CNMD 38.14
  • LIVN 66.62

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

About LIVN LivaNova PLC

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: